Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The University of Washington's Northwest Research Group on Aging is partnering with Area Agencies on Aging (AAA) in Washington and Oregon to complete this translational investigation of RDAD (Reducing Disabilities in Alzheimer's Disease). RDAD is an evidence-based program with demonstrated efficacy in helping older adults with dementia maintain physical function and remain physically and mentally healthy. This study asks two questions: 1) Can AAA partners successfully translate and implement RDAD, and 2) Is AAA implementation of RDAD effective in producing desired outcomes among agencies, providers, and older adults with dementia and their family members. This study is being conducted in Washington and Oregon states.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RDAD | Other | Exercise training for caregiver and care recipient. Behavior modification training for caregiver. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| RDAD | Behavioral | Exercise training for caregiver and care recipient. Behavioral modification training for caregiver. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Minutes of exercise per week | Caregivers will track the number of minutes per week the care recipients engage in exercise recommended by the coach. | Change from baseline in number of minutes of exercise each week during treatment phase of study, weeks 7-12 |
| Restricted Activity Days | Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness. | Baseline |
| Restricted Activity Days | Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness. | Change from Baseline to Pre-Treatment (6 weeks) |
| Restricted Activity Days | Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness. | Change from Baseline to Post- Treatment 1 (13 weeks) |
| Restricted Activity Days | Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness. | Change from Baseline to Post-Treatment 2 (30 weeks) |
| Restricted Days of Activity |
| Measure | Description | Time Frame |
|---|---|---|
| Revised Memory and Behavior Problem Checklist (RMBPC) | Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction. | Baseline |
| Revised Memory and Behavior Problem Checklist (RMBPC) |
Not provided
Inclusion Criteria:
Care Recipients must
Caregivers must
Exclusion Criteria:
Either Care-recipient or Caregiver must not
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Linda Teri, Ph.D. | University of Washington | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Washington | Seattle | Washington | 98195 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 30304477 | Derived | Teri L, Logsdon RG, McCurry SM, Pike KC, McGough EL. Translating an Evidence-based Multicomponent Intervention for Older Adults With Dementia and Caregivers. Gerontologist. 2020 Apr 2;60(3):548-557. doi: 10.1093/geront/gny122. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000544 | Alzheimer Disease |
| D003704 | Dementia |
| D008569 | Memory Disorders |
| D060825 | Cognitive Dysfunction |
| D009043 | Motor Activity |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D024801 | Tauopathies |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Restricted Activity Days measures how much the participant cut down his/her usual activities in the previous two weeks because of injury or illness and how many days the participant stayed in bed in the previous two weeks because of injury or illness. |
| Change from Baseline to 13 Month Follow-Up |
| Independence/Residential Status | All participants will be in independent living situations at baseline. Any move from independent living to a care facility will be documented throughout the 13 month study. | Change from Baseline to 13 Month Follow-Up |
Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction.
| Change from Baseline to Pre-Treatment (6 weeks) |
| Revised Memory and Behavior Problem Checklist (RMBPC) | Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction. | Change from Baseline to Post-Treatment 1 (13 weeks) |
| Revised Memory and Behavior Problem Checklist (RMBPC) | Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction. | Change from Baseline to Post-Treatment 2 (30 weeks) |
| Revised Memory and Behavior Problem Checklist (RMBPC) | Checklist rates 24 care recipient behaviors for frequency of occurrence and caregiver reaction. | Change from Baseline to 13 Month Follow-Up |
| Quality of Life-AD | This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults. | Baseline |
| Quality of Life-AD | This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults. | Change from Baseline to Pre-Treatment (6 weeks) |
| Quality of Life-AD | This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults. | Change from Baseline to Post-Treatment 1 (13 weeks) |
| Quality of Life-AD | This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults. | Change from Baseline to Post-Treatment 2 (30 weeks) |
| Quality of Life-AD | This 13-item measure is specifically designed for individuals with dementia and focuses on quality of life domains identified as important for cognitively impaired older adults. | Change from Baseline to 13 Month Follow-Up |
| CES-D | This 20-item scale that assesses depression in caregivers. | Baseline |
| CES-D | A 20-item scale that assesses depression in caregivers. | Change from Baseline to Pre-Treatment (6 weeks) |
| CES-D | A 20-item scale that assesses depression in caregivers. | Change from Baseline to Post-Treatment 1 (13 weeks) |
| CES-D | A 20-item scale that assesses depression in caregivers. | Change from Baseline to Post-Treatment 2 (30 weeks) |
| CES-D | A 20-item scale that assesses depression in caregivers. | Change from Baseline to 13 Month Follow-Up |
| D019636 |
| Neurodegenerative Diseases |
| D019965 | Neurocognitive Disorders |
| D001523 | Mental Disorders |
| D019954 | Neurobehavioral Manifestations |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D003072 | Cognition Disorders |
| D001519 | Behavior |